Phosphomannomutase 2 Deficiency

Explore clinical trials studying Phosphomannomutase 2 Deficiency. Study availability and eligibility vary by location and protocol.

4 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Phosphomannomutase 2 Deficiency trial results

Enrolling by Invitation

NCT06657859

Conditions: Congenital disorder of glycosylation type 1A, PMM2-CDG, Phosphomannomutase 2 Deficiency
Locations: University of Minnesota Minneapolis, Minnesota, United States

The Icahn School of Medicine at Mount Sinai New York, United States

The Children's Hospital of Philadelphia (CHOP) Philadelphia, Pennsylvania, United States

Seattle Children's Hospital Seattle, Washington, United States

View all 15 locations

Completed

NCT03173300

Conditions: Congenital disorder of glycosylation type 1A, Phosphomannomutase 2 Deficiency
Locations: Mayo Clinic College of Medicine Rochester, Minnesota, United States

Children's Hospital of Philadelphia (CHOP) Philadelphia, Pennsylvania, United States

Seattle Children's Hospital Seattle, Washington, United States

University Hospital Leuven Leuven, Belgium

Completed

NCT05549219

Conditions: Congenital disorder of glycosylation type 1A, PMM2-CDG, Phosphomannomutase 2 Deficiency
Locations: Clinical Research of West Florida Tampa, Florida, United States

Mayo Clinic Rochester, Minnesota, United States

Hospital Sant Joan de Déu Barcelona, Spain

Great Ormond Street Hospital London, United Kingdom

Active, Not Recruiting

NCT06892288

Conditions: Ataxia, Congenital disorder of glycosylation type 1A, Dyskinesias, +6 more
Locations: University of Minnesota Minneapolis, Minnesota, United States

Icahn School of Medicine at Mount Sinai New York, United States

The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

Seattle Children's Hospital Seattle, Washington, United States

View all 15 locations